36 results
8-K
EX-99.1
MAIA
MAIA Biotechnology Inc
4 Jun 24
Regulation FD Disclosure
4:06pm
of the J&J in the healthcare and Bayer (Nexavar), Oligonucleotide Center of manufacturing industries Astellas (Tarceva, Xtandi), Excellence Worldwide Active
424B5
MAIA
MAIA Biotechnology Inc
14 Feb 24
Prospectus supplement for primary offering
5:18pm
. Himmelreich served as the Director of Finance and Accounting at Avadim Health Inc., a healthcare-related private company, during which time he assisted
424B5
MAIA
MAIA Biotechnology Inc
17 Nov 23
Prospectus supplement for primary offering
9:06am
as the Director of Finance and Accounting at Avadim Health Inc., a healthcare-related private company, during which time he assisted with SEC filings of Avadim
8-K
014zb4
15 Nov 23
Termination of a Material Definitive Agreement
8:42am
FWP
fr9bop9 p7
11 Jul 23
Free writing prospectus
12:42pm
FWP
s57ft7 qeg0
9 Jun 23
Free writing prospectus
6:47am
DRS
rw27icvettza z1ms
1 Jun 23
Draft registration statement
12:00am
424B4
pmxfim 8b81c1kkrt
25 Apr 23
Prospectus supplement with pricing info
7:45pm
FWP
x4dk2f8p24xzl3nb
20 Apr 23
Free writing prospectus
9:38am
DEF 14A
2cz52
19 Apr 23
Definitive proxy
4:06pm
FWP
yzhh8fcwbwnr8y1xtn
18 Apr 23
Free writing prospectus
3:08pm
FWP
5xo3cyz6oz2c0t6
11 Apr 23
Free writing prospectus
8:30am
FWP
ro60was
6 Apr 23
Free writing prospectus
6:24pm
DRS
1nrq5 2glm5zmo
23 Dec 22
Draft registration statement
12:00am